236 related articles for article (PubMed ID: 37016051)
1. Chronic brain damage in HIV-infected individuals under antiretroviral therapy is associated with viral reservoirs, sulfatide release, and compromised cell-to-cell communication.
D'Amico D; Barone R; Di Felice V; Ances B; Prideaux B; Eugenin EA
Cell Mol Life Sci; 2023 Apr; 80(4):116. PubMed ID: 37016051
[TBL] [Abstract][Full Text] [Related]
2. Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.
Blomqvist M; Zetterberg H; Blennow K; Månsson JE
Mol Cell Neurosci; 2021 Oct; 116():103670. PubMed ID: 34562592
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
4. Sulfatide--a new candidate for ART treatment in HIV-1 infection.
Sundell IB; Cortado RV; Koka PS
J Stem Cells; 2012; 7(1):61-72. PubMed ID: 23550344
[TBL] [Abstract][Full Text] [Related]
5. Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection.
Gisslén M; Fredman P; Norkrans G; Hagberg L
AIDS Res Hum Retroviruses; 1996 Jan; 12(2):149-55. PubMed ID: 8834465
[TBL] [Abstract][Full Text] [Related]
6. White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy.
Solomon IH; Chettimada S; Misra V; Lorenz DR; Gorelick RJ; Gelman BB; Morgello S; Gabuzda D
Mol Neurobiol; 2020 Feb; 57(2):1115-1130. PubMed ID: 31691183
[TBL] [Abstract][Full Text] [Related]
7. White matter loss and oligodendrocyte dysfunction in HIV: A consequence of the infection, the antiretroviral therapy or both?
Jensen BK; Roth LM; Grinspan JB; Jordan-Sciutto KL
Brain Res; 2019 Dec; 1724():146397. PubMed ID: 31442414
[TBL] [Abstract][Full Text] [Related]
8. High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications.
Gisslén M; Lekman A; Fredman P
J Neuroimmunol; 1999 Feb; 94(1-2):153-6. PubMed ID: 10376948
[TBL] [Abstract][Full Text] [Related]
9. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
[TBL] [Abstract][Full Text] [Related]
10. The Role of Pannexin-1 Channels in HIV and NeuroHIV Pathogenesis.
Hernandez CA; Eliseo E
Cells; 2022 Jul; 11(14):. PubMed ID: 35883688
[TBL] [Abstract][Full Text] [Related]
11. Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities.
León-Rivera R; Morsey B; Niu M; Fox HS; Berman JW
mBio; 2020 Jul; 11(4):. PubMed ID: 32723919
[TBL] [Abstract][Full Text] [Related]
12. Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.
Perez S; Johnson AM; Xiang SH; Li J; Foley BT; Doyle-Meyers L; Panganiban A; Kaur A; Veazey RS; Wu Y; Ling B
J Neurovirol; 2018 Feb; 24(1):62-74. PubMed ID: 29181724
[TBL] [Abstract][Full Text] [Related]
13. Clinical contributors to cerebral white matter integrity in HIV-infected individuals.
Gongvatana A; Cohen RA; Correia S; Devlin KN; Miles J; Kang H; Ombao H; Navia B; Laidlaw DH; Tashima KT
J Neurovirol; 2011 Oct; 17(5):477-86. PubMed ID: 21965122
[TBL] [Abstract][Full Text] [Related]
14. Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy.
Lopate G; Pestronk A; Evans S; Li L; Clifford D
Neurology; 2005 May; 64(9):1632-4. PubMed ID: 15883332
[TBL] [Abstract][Full Text] [Related]
15. HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS.
Berman JW; Carvallo L; Buckner CM; Luers A; Prevedel L; Bennett MV; Eugenin EA
J Neuroinflammation; 2016 Mar; 13(1):54. PubMed ID: 26934876
[TBL] [Abstract][Full Text] [Related]
16. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa.
Hoare J; Fouche JP; Phillips N; Joska JA; Paul R; Donald KA; Thomas KG; Stein DJ
AIDS; 2015 Sep; 29(14):1793-801. PubMed ID: 26372385
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems.
Malik S; Eugenin EA
Curr HIV Res; 2016; 14(5):400-411. PubMed ID: 27009098
[TBL] [Abstract][Full Text] [Related]
18. Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs.
Darcis G; Berkhout B; Pasternak AO
Viruses; 2020 Apr; 12(5):. PubMed ID: 32349381
[TBL] [Abstract][Full Text] [Related]
19. White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment.
Su T; Caan MW; Wit FW; Schouten J; Geurtsen GJ; Cole JH; Sharp DJ; Vos FM; Prins M; Portegies P; Reiss P; Majoie CB;
AIDS; 2016 Jan; 30(2):311-22. PubMed ID: 26691551
[TBL] [Abstract][Full Text] [Related]
20. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth.
Winzeler AM; Mandemakers WJ; Sun MZ; Stafford M; Phillips CT; Barres BA
J Neurosci; 2011 Apr; 31(17):6481-92. PubMed ID: 21525289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
